Summary
Apoptosis is the mechanism by which cells are programmed to die under a wide range of physiological and developmental stimuli. Accumulating evidence indicates that enhanced apoptosis (programmed cell death) in Down syndrome (DS) may play a role in mental retardation and precocious neurodegeneration of the Alzheimer-type. In this regard, alteration of several apoptosis related proteins have been reported in adult DS brain. Fetal DS neurons exhibited increased reactive oxygen species leading to early apoptosis, however, expression of apoptosis related proteins in fetal DS, has never been considered. To address this issue, we investigated the expression of proteins involved in apoptosis including Fas (CD95, APO-1), caspase-3, Bcl-2 and annexins in the cerebral cortex of control and DS fetal brain by western blot and two dimensional electrophoresis. Here, we report that no detectable changes were obtained in fetal DS brain in the expression of Fas, caspase-3, Bcl-2 and Annexins (I, II, V, and VI) compared to controls. In parallel experiment, we also examined the expression of neuron specific enolase (NSE), a neuronal marker found to be decreased in adult DS brain, to see if there is any neuronal loss and no difference was observed between the two groups. Protein expression did not correlate with age. The unchanged levels of Fas, Bcl-2 and annexins together with unaltered caspase-3 expression, a predominant caspase that executes apoptosis in the developing nervous system, suggest that enhanced apoptosis may not be apparent in fetal DS brain as demonstrated for adult DS brain.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adayev T, Estephan R, Meserole S, Mazza B, Yurkow EJ, Banerjee P (1998) Externalization of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine-displaying apoptosis cells are phagocytosed by microglia. J Neurochem 71: 1854–1864
Anderson AJ, Stoltzner S, Lai Florence Su J, Nixon RA (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer’s disease, and effect of postmortem tissue archival on TUNEL. Neurobiol Aging 21: 511–524
Becher B, Barker PA, Owens T, Antel PJ (1998a) CD95-CD95L: can the brain learn from the immune system? Trends Neurosci 21: 114–117
Becher B, D’Souza SD, Troutt AB, Antel JP (1998b) Fas expression on human fetal astrocytes without susceptibility to fas mediated toxicity. Neuroscience 84: 627–634
Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521–3526
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Busciglio J, Yanker BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome in vitro. Nature 378: 776–779
Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, Perretti M (2000) Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin 1). Life Sci 66: PL265–270
Chan WY, Yew DT (1998) Apoptosis and Bcl-2 oncoprotein expression in the human fetal central nervous system. Anat Rec 252: 165–175
Cheema ZF, West JR, Miranda RC (2000) Ethanol induces Fas/APO mRNA and cell suicide in the developing cerebral cortex. Alcohol Clin Exp Res 24: 535–543
Chiang Y, Rizzino A, Sibenaller ZA, Wold MS, Vishwanatha JK (1999) Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 199: 139–147
Creutz CE (1992) The annexins and exocytosis. Science 258: 924–931
Dragunow M, MacGibbon GA, Lawlor P, Butterworth N, Connor B, Henderson C, Walton M, Woodgate A, Hughes P, Faull RL (1997) Apoptosis, neurotrophic factors and neurodegeneration. Rev Neurosci 8: 223–265
Epstein CJ (1995) Down Syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn, vol I. McGraw Hill, New York, pp 749–794
Fountoulakis M, Langen H (1997) Identification of proteins by matrix assisted laser desorption ionization mass spectrometry following in-gel digestion in low salt, nonvolatile buffer and simplified peptide recovery. Anal Biochem 250: 153–156
Francis JW, Balazovich KJ, Smolen JE, Margolis DI, Boxer LA (1992) Human neutrophil annexin I promotes granule aggregation and modulates Ca2+ dependent membrane fusion. J Clin Invest 90: 537–544
Gidon-Jeangirard C, Hugel B, Holl V, Toti F, Laplanche JL, Meyer D, Freyssinet JM (1999a) Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. J Immunol 162: 5712–5718
Gidon-Jeangirard C, Solito E, Hofmann A, Russo-Marie F, Freyssinet JM, Martinez MC (1999b) Annexin V counteracts apoptosis while inducing Ca2+ influx in human lymphocytic T cells. Biochem Biophys Res Commun 265: 709–715
Gulesserian T, Engidawork E, Cairns N, Lubec G (2000) Increased serotonin protein levels in frontal cortex of patients with Down syndrome. Neurosci Lett 296: 53–57
Gulesserian T, Engidawork E, Yoo BC, Cairns N, Lubec G (2001) Alteration of caspases and their regulatory proteins in brains of Down syndrome. J Neural Transm (this volume)
Hutchins JB, Barger SW (1998) Why neurons die: cell death in the nervous system. Anat Rec 253: 79–90
Johnson MD, Kamso-Pratt JM, Whetsell WO, Pepinsky RB (1989) Lipocortin-1 immu-noreactivity in the normal human central nervous system and lesions with astrocytosis. Am J Clin Pathol 92: 424–429
Kaetzel MA, Hazarika P, Dedman JR (1989) Differential distribution of three 35-kDa annexin calcium dependent phospholipid binding proteins. J Biol Chem 264: 14463–14470
Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 3: 614–620
Krosmeyer SJ (1995) Regulators of cell death. Trends Genet 11: 101–105
Kuan C-Yi, Roth KA, Flavell RA, Rakic P (2000) Mechanisms of programmed cell death in the developing brain. Trends Neurosci 23: 291–297
Langen H, Röder D, Juranville JF, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two dimensional gel electrophoresis. Electrophoresis 18: 2085–2090
Maiese K, Vincent AM (2000) Membrane asymmetry and DNA degradation: Functionally distinct determinants of neuronal programmed cell death. J Neurotics 59: 568–580
Mann DM (1988) The pathological association between Down syndrome and Alzheimer disease. Mech Aging Div 43: 99–136
Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR (1995) Early redistribution of plasma membrane phosphatidylserine externalization is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545–1556
McKanna JA (1995) Lipocortin I in apoptosis: mammary regression. Anat Rec 242: 1–10
Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ (1994) Bcl-2 expression is widespread in the developing nervous system and retained in the adult PNS. Development 120: 301–311
Osterloh D, Wittbrodt J, Gerke V (1998) Characterization and developmentally regulated expression of four annexins in the killifish medaka: DANN. Cell Biol 17: 835–847
Rao L, White E (1997) Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Gene Dev 7: 52–58
Raynal P, Pollard MB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium and phospholipid binding proteins. Biochem Biophys Acta 1197: 63–93
Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M, Israel MA (1992) Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 52: 6871–6876
Reutelingsperger CP, van Heerde WL (1997) Annexin V, the regulator of phosphatidylserine catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 53: 527–532
Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS (2000) Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 267: 3220–3225
Sakamoto T, Repasky WT, Uchida K, Hirata A, Hirata F (1996) Modulation of cell death pathways to apoptosis and necrosis of H202 treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 220: 643–647
Saphier CJ, Yeh J (1998) Altered apoptosis levels in hearts of human fetuses with Down syndrome. Am J Obstet Gynecol 179: 962–965
Sawa A, Oyama F, Cairns N, Amano N, Matsushita M (1997) Aberrant expression of Bcl-2 gene family in Down’s syndrome brains. Mol Brain Res 48: 53–59
Seidl R, Fang-Kircher S, Bidmon B, Cairns N, Lubec G (1999) Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett 260: 9–12
Shimohama S, Tanino H, Fujimoto S (1999) Changes in caspase expression in Alzheimer’s disease: comparison with development and aging. Biochem Biophys Res Commun 256: 381–384
Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomasselli KJ (1998) In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Diff 5: 1004–1016
Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312–1322
Tzima E, Walker JH (2000) Platelet annexin V: the ins and outs. Platelets 11: 542– 251
Vermes I, Steur EN, Reutelingsperger C, Haanen C (1999) Decreased concentration of annexin V in Parkinsonian cerebrospinal fluid: speculation on the underlying cause. Mov Disord 14: 1008–1010
Wang S, Dibenedetto AJ, Pittman RN (1997) Genes induced in programmed cell death of neuronal PC12 cells and developing sympathetic neurons in vivo. Dev Biol 188: 322–336
Wang S, Rosengren LE, Franlund M, Hamberger A, Haglid KG (1999) Bcl-2 expression regulates cell sensitivity to S100ß mediated apoptosis. Mol Brain Res 70: 167–176
Wisniewski KE, Kida E (1994) Abnormal neurogenesis and synaptogenesis in Down syndrome brain. Dev Brain Dysfunct 7: 289–301
Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down syndrome. Ann Neurol 17: 278–282
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag/Wien
About this chapter
Cite this chapter
Engidawork, E., Balic, N., Juranville, JF., Fountoulakis, M., Dierssen, M., Lubec, G. (2001). Unaltered expression of Fas (CD95/APO-1), Caspase-3, Bcl-2 and Annexins in brains of fetal Down syndrome: evidence against increased apoptosis. In: Lubec, G. (eds) Protein Expression in Down Syndrome Brain. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6262-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6262-0_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83704-7
Online ISBN: 978-3-7091-6262-0
eBook Packages: Springer Book Archive